SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-065482
Filing Date
2023-11-21
Accepted
2023-11-21 16:05:15
Documents
14
Period of Report
2023-11-21
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K stro-20231121.htm   iXBRL 8-K 44728
2 EX-99.1 stro-ex99_1.htm EX-99.1 12804
3 GRAPHIC img217863751_0.jpg GRAPHIC 5459
  Complete submission text file 0000950170-23-065482.txt   190285

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stro-20231121.xsd EX-101.SCH 2464
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT stro-20231121_lab.xml EX-101.LAB 14690
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stro-20231121_pre.xml EX-101.PRE 11050
8 EXTRACTED XBRL INSTANCE DOCUMENT stro-20231121_htm.xml XML 4753
Mailing Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BLVD. SOUTH SAN FRANCISCO CA 94080 650-392-8412
SUTRO BIOPHARMA, INC. (Filer) CIK: 0001382101 (see all company filings)

IRS No.: 452441988 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38662 | Film No.: 231428050
SIC: 2836 Biological Products, (No Diagnostic Substances)